When was Biocomposites founded?

Biocomposites was founded in 1999 and raised its 1st funding round 18 years after it was founded.

Where is Biocomposites located?

Biocomposites is headquartered in Keele, United Kingdom. It is registered at C/O BIOCOMPOSITES LIMITED KEELE SCIENCE PARK,KEELE,NEWCASTLE,STAFFS,ST5 5NL.

Which legal entities is Biocomposites associated with?

Biocomposites is associated with BIOCOMPOSITES (UK) LIMITED and 3 others.

How many employees does Biocomposites have?

As of Mar 01, 2026, the latest employee count at Biocomposites is 50 - 199.

Is Biocomposites a funded company?

Biocomposites is a funded company, having raised a total of $1.8M across 2 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Mar 31, 2017.

How much is Biocomposites worth?

The latest valuation of Biocomposites is $***** as of May 31, 2017.

When was the latest funding round of Biocomposites?

Biocomposites' latest funding was a $***** Unattributed round on Mar 03, 2025, with participation from 2 investors. Its primary sector is Orthopedics. In United Kingdom, the Orthopedics sector has seen $48.1M in funding in 2026 to date.

What is the annual revenue of Biocomposites?

Annual revenue of Biocomposites is between £10M and £50M as on Dec 31, 2016

Where does Biocomposites rank among its competitors?

Biocomposites ranks 5th amongst 131 active competitors, of which 43 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Theradaptive, which secured $36.2M in Jul, 2026.

Who are the top competitors of Biocomposites?

Biocomposites' top competitors include Ossio, RevBio and Theradaptive. Among them, Theradaptive secured the most recent funding round in July, 2026.

Biocomposites - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of synthetic calcium composite products for bone repair and regeneration. The products include STIMULAN an absorbable calcium sulfate designed to be placed directly at the site of infection in bone and soft tissues. genex ia a synthetic bone graft substitute aimed at supporting natural bone healing, Biosteon is an osteoconductive calcium phosphate composite, Allogran‑R & Bilok used in trauma, spine, and sports injury applications, and NanoBone SBX Putty/QD is a nanostructured hydroxyapatite grafts cleared for interbody spinal fusion.

Website: biocomposites.com
Phone Number: +44 **********
Registered Address: C/O BIOCOMPOSITES LIMITED KEELE SCIENCE PARK,KEELE,NEWCASTLE,STAFFS,ST5 5NL

Key Metrics

Founded Year

1999

Location

Keele, United Kingdom

Stage

Early Stage

Total Funding

$1.8M in 2 rounds

Latest Funding Round

Unattributed, Mar 03, 2025, $*****

Post Money Valuation

$***** as on May 31, 2017

Investors

TA Associates & 9 more

Ranked

5^th among 131 active competitors

Annual Revenue

£10M - £50M as on Dec 31, 2016

Employee Count

50 - 199 as on Mar 01, 2026

Investment & Acquisitions

Renovos & 1 more

Similar Companies

Ossio & 162 more

View Biocomposites' full profile

Biocomposites is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
BIOCOMPOSITES (UK) LIMITED CIN: 3854291 , United Kingdom, Active	Oct 05, 1999	£10M - £50M (As on Dec 31, 2016)	-
Biocomposites Limited CIN: F06149 , India, Inactive for e-filing	Jan 10, 2017	-	-
Biocomposites Limited CIN: 3291943 , United Kingdom, Active	Dec 12, 1996	-	-
BIOCOMPOSITES INDIA PRIVATE LIMITED CIN: U51909DL2019FTC355386 , India, Active	Sep 23, 2019	0 - ₹10 Cr (As on Mar 31, 2021)	25 (As on Mar 31, 2024)

Biocomposites has raised a total funding of $1.8M over 2 rounds. Its first funding round was on Mar 31, 2017. Its latest funding round was a Unattributed round on Mar 03, 2025 for $*****. 2 investors participated in its latest round. Biocomposites has 5 institutional investors and 5 angel investors.

Here is the list of recent funding rounds of Biocomposites:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 03, 2025	5105148	Unattributed	1317603	3391417	7014354	7269622
Mar 31, 2017	6871868	Unattributed	1624194	1240351	TA Associates	3857390

Access funding benchmarks and valuations. Sign up today!

View details of Biocomposites's funding rounds and investors

The founders of Biocomposites are John Joseph Cooper, Russell David Waters and John Stephen Bratt.

Here are the details of Biocomposites' key team members:

John Joseph Cooper: Co-Founder of Biocomposites. They serve on the board of 1 company.
Russell David Waters: Co-Founder of Biocomposites. They serve on the board of 1 company.
John Stephen Bratt: Co-Founder of Biocomposites. They serve on the board of 1 company.

Biocomposites' Board of Directors

Biocomposites's board has 3 active members. John Stephen Bratt is part of team and Simon Mia Fitzer and Michael John Hesp are independent board members.

Here is the list of Biocomposites' board of directors:

Name	Type	Representing	Status	Duration
John Stephen Bratt	Team	-	Current	26y 8m
gxsgqyu	Team	-	Past	6y 7m
wdvz{le	Team	-	Past	6y 5m
e{ymtqt	Investor	-	Past	8y 3m
Simon Mia Fitzer	Independent board member	-	Current	9y 3m
j{pjxsu	Independent board member	-	Current	5y 3m
{htumwa	Independent board member	-	Past	8y 7m
oamk{ox	Independent board member	-	Past	9y 2m
xyagfwf	Independent board member	-	Past	1y 6m

View details of Biocomposites's Founder profiles and Board Members

Biocomposites' employee count trend

Biocomposites has 50 - 199 employees as of Mar 26. Here is Biocomposites's employee count trend over the years:

Uncover Biocomposites' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Biocomposites include Ossio, RevBio and Theradaptive. Here is the list of Top 10 competitors of Biocomposites, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ossio 2014, Caesarea (Israel), Series C	Bone regeneration biocomposite	$89M	MVM, Questa Capital & 7 others	64/100
2nd	RevBio 2014, Lowell (United States), Series B	Developer of synthetic adhesive used for bone/dental repair	$27.5M	Pacific Dental Services, The JHA Capital & 4 others	63/100
3rd	Theradaptive 2004, Boston (United States), Series B	Developer of protein engineering technology creating targeted therapeutics for tissue repair	$50M	TEDCO, Defense.gov & 4 others	61/100
4th	MiMedx Group 1985, Marietta (United States), Public	Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics	-	Hayfin, Trelys & 4 others	61/100
5th	Biocomposites 1999, Keele (United Kingdom), Early Stage	Developer of synthetic calcium composite products for bone repair and regeneration	$1.8M	TA Associates, Novo Holdings & 8 others	59/100
6th	Cerapedics 1996, Westminster (United States), Series D	Developer of Osteobiologic products	$88.5M	Orbimed, MedImmune Ventures & 5 others	58/100
7th	Serigen 2015, Pune (India), Seed	Develops silk protein-based biomedical products for tissue regeneration and healing	$3.63M	Indian Angel Network, Pandit Nominees & 62 others	53/100
8th	Tissue Regenix 2006, Swillington (United Kingdom), Public	Developer of regenerative medical devices by using cell technology	-	Harwood Capital, IP Group & 2 others	53/100
9th	Epibone 2013, Brooklyn (United States), Series B	Developer of patient‑specific bone and cartilage grafts	$48.6M	Kendall Capital Partners, MBX Capital & 25 others	51/100
10th	Royal Biologics 2015, Jersey City (United States), Series A	Innovating orthobiologics and wound care solutions for enhanced healing	$19.6M	Granite Creek Capital Partners	47/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Biocomposites's competitors? Click here to see the top ones

Founders (largest shareholder) own 63.40%, Funds own 5.10%, Enterprises own 0.00% and Angels own 25.30%. The net worth of Biocomposites's founders is INR 22.2M as of May 31, 2017.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	63.40%	22.2M	6971285	2688048	8441632	9822135
John Stephen Bratt	3120150	3989681	9772548	2688874	2915026	2906147
John Joseph Cooper	6072939	6059220	3732225	2312714	8671366	8697365
Russell David Waters	4819363	2141901	3206059	4736727	9816680	3851799
Fund	5.10%	1.78M	24538	25633	46557	10424
TA Associates	54931	23913	69317	52938	45437	97088
Enterprise	-	0	0	0	0	0
Angel	25.30%	8.86M	7859684	6583155	6006782	1884419
Total	93.80%	3.29Cr	5939159	1532555	6208761	6713076